News

The 6 Largest Biopharma Layoffs of 2024 So Far

Collage of businesses/Taylor Tieden for BioSpace The financial markets have surged thus far in 2024, recovering from post-pandemic slumps and even reaching new heights. Yet biopharma layoff trends have remained high. Biotech and pharma layoffs […]

[adinserter block="2"]
News

ALLOSOURCE® LAUNCHES ACECONNEX®, FIRST PRE-SUTURED FASCIA DEVICE FOR HIP LABRAL RECONSTRUCTION AND AUGMENTATION

AceConnex Pre-Sutured Fascia is specifically designed for hip arthroscopists to help increase efficiency by reducing operating room time CENTENNIAL, Colo., June 11, 2024 /PRNewswire/ — AlloSource®, one of the largest allograft providers creating innovative cellular […]

News

Ancestry Unveils New Collection of Newspaper Articles Related to Enslaved People in the United States Pre-1870

Available to everyone at no cost, the new Articles of Enslavement collection will help descendants of previously enslaved people make family history discoveries LEHI, Utah, June 11, 2024 /PRNewswire/ — Today Ancestry®, the global leader […]

No Picture
News

Weekly Policy Blog: CBSA Policy News Roundup—BIO International Convention and Prescription Drug Affordability Events 

This past week, the CBSA team represented our community and shared our expertise on prescription drug affordability at the BIO International Convention and through a series of virtual events:  Elyse Blazevich, CBSA President and CEO, […]

[adinserter block="2"]
News

S3 Collective, a Cannabis Non-Profit, Forms Governmental Advisory Committee Supporting Scientific Standards to Enhance the Quality and Safety of Cannabinoid Products

COLORADO SPRINGS, Colo., June 10, 2024 /PRNewswire/ — S3 Collective, a national nonprofit organization dedicated to advancing the cannabis industry through collaboration, education, and standardization, is proud to announce the formation of its Governmental Advisory […]

No Picture
News

4DMT Presents Injection-Free Subgroup Analyses from 4D-150 Phase 2 PRISM Randomized Dose Expansion Cohort in Wet AMD Patients with Severe Disease Activity & High Treatment Burden at the Clinical Trials at the Summit 2024 Meeting

EMERYVILLE, Calif., June 08, 2024 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading clinical-stage genetic medicines company focused on unlocking the full potential of genetic medicines to treat large market […]

[adinserter block="2"]